People in Addiction Recovery Less Likely to Get Effective Depression Care

National veterans’ study points to need for better support for people facing both conditions at once.

10:14 AM

Author | Kara Gavin

drawing in blue ink of drugs and syringes
Stephanie King

Veterans getting care for substance use disorders who get diagnosed with depression are less likely to receive optimal care for than other veterans, according to a new study. That includes both treatment based on antidepressants, and treatment based on "talk therapy" methods.

The findings, based on an analysis of records from more than 53,000 veterans across the country who received a new diagnosis of depression in 2017, are published in the American Journal of Psychiatry by a team from the University of Michigan and the VA Ann Arbor Healthcare System.  

"Veterans with depression and substance use disorders receive lower quality depression treatment than those without substance use disorders, despite best practices recommending treating both conditions concurrently," says lead author Lara Coughlin, Ph.D. "This is true both for medication and psychotherapy, highlighting the need to address comorbid depression in SUD patients and also the importance of thinking about the SUD population for the depression field."

Even after adjusting for differences in personal characteristics, the study shows that patients with substance use disorders had a 21% lower chance of getting initial antidepressant medication treatment for depression that aligned with best-practice guidelines, and 26% lower chance of receiving continued antidepressant treatment. The difference between the two groups was smaller but still significant for psychotherapy.

In addition to highlighting the disparities between the two groups, the study also shows that nearly half of all veterans diagnosed with depression still don't receive treatment that aligns with guidelines for depression care, whether or not they also have a history of substance use disorder. Only about a third of all the veterans in the study received psychotherapy for depression in the 90 days after their diagnosis. 

Coughlin is an assistant professor in the U-M Department of Psychiatry and member of the U-M Addiction Center. The clinical program of that center, U-M Addiction Treatment Services, offers a comprehensive range of services to help treat mild to severe substance use disorders with co-occurring depression.

Paper cited: "Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder," American Journal of Psychiatry. DOI: 10.1176/appi.ajp.2020.20040454

More Articles About: Lab Notes Addiction and Substance Abuse Depression Mental Health
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories Firearms and mental health
Health Lab
Firearms and mental health: 8 top facts to know
For people with mental health conditions, whether diagnosed or not, easy firearm access during a crisis can be dangerous. There experts offer tips for how to reduce the risk.
orange background, blue skull, brain maze inside large brain and person with white coat looking at it with a magnifying glass
Health Lab
Uncovering mysteries of the developing brain
The ABCD study, a long-term study of the brains of thousands of young people from preteen to late teen years, is revealing important insights into behavior and mental health.
mom smiling with 3 kids
Health Lab
Adolescents with heart disease learn resilience skills, connect with peers through unique program
Youth with heart disease enrolled in unique program that teaches resilience and builds connections with their peers
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Presenting: The Fundamentals
Today on Health Lab, we are sharing an episode of The Fundamentals, another podcast from the Michigan Medicine Podcast Network that just launched its second season earlier this month. On this episode of The Fundamentals: "Cannabis and psychedelics: stigmatized substances or powerful therapeutics?" Dr. Kevin Boehnke talks about cannabis, psychedelics, and the increasing body of evidence for their legitimization as therapeutics.
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Treating Diabetes & Weight: The Ozempic & Wegovy Effect
Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.